Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
about
Pharmacological management for agitation and aggression in people with acquired brain injuryThe role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients.Agitation following traumatic brain injury: an Australian sample.A review of pharmacological treatments used in experimental models of traumatic brain injury.Off-label use of antipsychotics: are we mad?Agitation after traumatic brain injury and predictors of outcome.
P2860
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@ast
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@en
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@nl
type
label
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@ast
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@en
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@nl
prefLabel
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@ast
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@en
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@nl
P2093
P356
P1433
P1476
Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
@en
P2093
P304
P356
10.1080/026990501458399
P577
2001-02-01T00:00:00Z